CN112957307B - 乳酸菌发酵的桦树汁及其在抗衰老化妆品组合物中的应用 - Google Patents
乳酸菌发酵的桦树汁及其在抗衰老化妆品组合物中的应用 Download PDFInfo
- Publication number
- CN112957307B CN112957307B CN201911189170.8A CN201911189170A CN112957307B CN 112957307 B CN112957307 B CN 112957307B CN 201911189170 A CN201911189170 A CN 201911189170A CN 112957307 B CN112957307 B CN 112957307B
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- birch juice
- birch
- fermented
- juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000018185 Betula X alpestris Nutrition 0.000 title claims abstract description 170
- 235000018212 Betula X uliginosa Nutrition 0.000 title claims abstract description 170
- 235000011389 fruit/vegetable juice Nutrition 0.000 title claims abstract description 141
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 84
- 239000004310 lactic acid Substances 0.000 title claims abstract description 42
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 42
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 38
- 241000894006 Bacteria Species 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 238000000855 fermentation Methods 0.000 claims abstract description 63
- 230000004151 fermentation Effects 0.000 claims abstract description 63
- 235000013365 dairy product Nutrition 0.000 claims abstract description 23
- 239000000706 filtrate Substances 0.000 claims description 62
- 239000000047 product Substances 0.000 claims description 53
- 241000186660 Lactobacillus Species 0.000 claims description 40
- 229940039696 lactobacillus Drugs 0.000 claims description 40
- 238000001914 filtration Methods 0.000 claims description 29
- 239000001963 growth medium Substances 0.000 claims description 29
- 239000006166 lysate Substances 0.000 claims description 28
- 238000002156 mixing Methods 0.000 claims description 26
- 239000002609 medium Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 19
- 244000199866 Lactobacillus casei Species 0.000 claims description 17
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 17
- 229940017800 lactobacillus casei Drugs 0.000 claims description 17
- 239000006228 supernatant Substances 0.000 claims description 15
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 14
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 14
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 14
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 14
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 241000191996 Pediococcus pentosaceus Species 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 9
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 9
- 235000013336 milk Nutrition 0.000 claims description 8
- 239000008267 milk Substances 0.000 claims description 8
- 210000004080 milk Anatomy 0.000 claims description 8
- 239000006227 byproduct Substances 0.000 claims description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 3
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 description 26
- 210000003491 skin Anatomy 0.000 description 26
- 230000001954 sterilising effect Effects 0.000 description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- 230000037303 wrinkles Effects 0.000 description 20
- 238000003756 stirring Methods 0.000 description 18
- 239000012071 phase Substances 0.000 description 16
- -1 but not limited to Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 15
- 150000004676 glycans Chemical class 0.000 description 15
- 229920001282 polysaccharide Polymers 0.000 description 15
- 239000005017 polysaccharide Substances 0.000 description 15
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 238000004659 sterilization and disinfection Methods 0.000 description 14
- 230000001580 bacterial effect Effects 0.000 description 13
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 12
- 239000006071 cream Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 239000012528 membrane Substances 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 102000004196 processed proteins & peptides Human genes 0.000 description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 241000186000 Bifidobacterium Species 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 108010046377 Whey Proteins Proteins 0.000 description 9
- 239000000919 ceramic Substances 0.000 description 9
- 230000001804 emulsifying effect Effects 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 229920001184 polypeptide Polymers 0.000 description 9
- 235000021119 whey protein Nutrition 0.000 description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 description 8
- 229940010747 sodium hyaluronate Drugs 0.000 description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 8
- 102000007544 Whey Proteins Human genes 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 238000004945 emulsification Methods 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 7
- 239000011550 stock solution Substances 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 241001052560 Thallis Species 0.000 description 5
- 229930182478 glucoside Natural products 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 239000010802 sludge Substances 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- 241000238582 Artemia Species 0.000 description 4
- 241001520764 Betula pubescens Species 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000007599 discharging Methods 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000012263 liquid product Substances 0.000 description 4
- 229940099596 manganese sulfate Drugs 0.000 description 4
- 235000007079 manganese sulphate Nutrition 0.000 description 4
- 239000011702 manganese sulphate Substances 0.000 description 4
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 235000002992 Betula pubescens Nutrition 0.000 description 3
- 108010016626 Dipeptides Proteins 0.000 description 3
- 241000192132 Leuconostoc Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- KLOIYEQEVSIOOO-UHFFFAOYSA-N carbocromen Chemical compound CC1=C(CCN(CC)CC)C(=O)OC2=CC(OCC(=O)OCC)=CC=C21 KLOIYEQEVSIOOO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 229940105132 myristate Drugs 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- OGNHOGPWQTWKGQ-VGWMRTNUSA-N (2S)-5-amino-2-[[(2S)-1-[2-[[(2S)-5-amino-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 OGNHOGPWQTWKGQ-VGWMRTNUSA-N 0.000 description 2
- CCLARULDIPFTCP-BOYHRMMASA-N (2r,3r,4r,5s)-heptane-1,2,3,4,5,6-hexol Chemical compound CC(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CCLARULDIPFTCP-BOYHRMMASA-N 0.000 description 2
- LODWEXDBRZBADB-XEVVZDEMSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-methylbutanoyl]amino]hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O LODWEXDBRZBADB-XEVVZDEMSA-N 0.000 description 2
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 229940035437 1,3-propanediol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 235000003320 Adansonia digitata Nutrition 0.000 description 2
- 244000056974 Adansonia digitata Species 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000003932 Betula Nutrition 0.000 description 2
- 241000219429 Betula Species 0.000 description 2
- 235000009109 Betula pendula Nutrition 0.000 description 2
- 241000219430 Betula pendula Species 0.000 description 2
- 241000219495 Betulaceae Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
- 108010087806 Carnosine Proteins 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- 235000004496 Oenothera biennis Nutrition 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 241000192001 Pediococcus Species 0.000 description 2
- 235000010453 Pterocarpus marsupium Nutrition 0.000 description 2
- 240000008976 Pterocarpus marsupium Species 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 description 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 description 2
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229940044199 carnosine Drugs 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000021579 juice concentrates Nutrition 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002068 microbial inoculum Substances 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229940094912 palmitoyl tripeptide-5 Drugs 0.000 description 2
- 229940101267 panthenol Drugs 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 229940100460 peg-100 stearate Drugs 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 239000004323 potassium nitrate Substances 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- 229940078492 ppg-17 Drugs 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 229940001584 sodium metabisulfite Drugs 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- LBTVHXHERHESKG-UHFFFAOYSA-N tetrahydrocurcumin Chemical compound C1=C(O)C(OC)=CC(CCC(=O)CC(=O)CCC=2C=C(OC)C(O)=CC=2)=C1 LBTVHXHERHESKG-UHFFFAOYSA-N 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WQKLGQXWHKQTPO-UXRZSMILSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol;2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WQKLGQXWHKQTPO-UXRZSMILSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 description 1
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 description 1
- QZLXCFQVOCEKSX-NOCHOARKSA-N (2s,4r)-1-hexadecanoyl-4-hexadecanoyloxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H]1C[C@@H](C(O)=O)N(C(=O)CCCCCCCCCCCCCCC)C1 QZLXCFQVOCEKSX-NOCHOARKSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- GJVUMEONPPTZEY-UHFFFAOYSA-N 2,3-dihydroxypropyl undec-10-enoate Chemical compound OCC(O)COC(=O)CCCCCCCCC=C GJVUMEONPPTZEY-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000125300 Argania sideroxylon Species 0.000 description 1
- 235000016108 Argania sideroxylon Nutrition 0.000 description 1
- 235000001553 Betula platyphylla Nutrition 0.000 description 1
- 241001313086 Betula platyphylla Species 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 241001134772 Bifidobacterium pseudocatenulatum Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001534 FEMA 4201 Substances 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 235000015164 Iris germanica var. florentina Nutrition 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 241000110847 Kochia Species 0.000 description 1
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 241000218492 Lactobacillus crispatus Species 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000509544 Lactobacillus gallinarum Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- BVTHRGZMQHOCOL-UHFFFAOYSA-N OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO Chemical compound OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO BVTHRGZMQHOCOL-UHFFFAOYSA-N 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 240000008916 Oenothera biennis Species 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- 235000000857 Pentadesma butyracea Nutrition 0.000 description 1
- 240000002134 Pentadesma butyracea Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 235000000539 Rosa canina Nutrition 0.000 description 1
- 240000008530 Rosa canina Species 0.000 description 1
- 235000010337 Rosa dumalis Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 241001522306 Serinus serinus Species 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- LZDNBBYBDGBADK-KBPBESRZSA-N Val-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-KBPBESRZSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 description 1
- NENOAJSZZPODGJ-OIMNJJJWSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octanoate Chemical compound CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NENOAJSZZPODGJ-OIMNJJJWSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940011403 apple seed extract Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- PXTQQOLKZBLYDY-UHFFFAOYSA-N bis(2-ethylhexyl) carbonate Chemical compound CCCCC(CC)COC(=O)OCC(CC)CCCC PXTQQOLKZBLYDY-UHFFFAOYSA-N 0.000 description 1
- ILMMCBFQWHPTHE-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O.CCCC(O)O ILMMCBFQWHPTHE-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940083913 c14-22 alcohols Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- PXGZQGDTEZPERC-UHFFFAOYSA-L cyclohexane-1,4-dicarboxylate Chemical compound [O-]C(=O)C1CCC(C([O-])=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-L 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 229940093497 ergothioneine Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 229940045761 evening primrose extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940049654 glyceryl behenate Drugs 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229940049290 hydrogenated coco-glycerides Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 244000023249 iris florentino Species 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940115478 isopropyl lauroyl sarcosinate Drugs 0.000 description 1
- 235000021581 juice product Nutrition 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 230000011890 leaf development Effects 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000020191 long-life milk Nutrition 0.000 description 1
- 235000020121 low-fat milk Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940120511 oleyl erucate Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000020200 pasteurised milk Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 description 1
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 229940116393 ppg-20 methyl glucose ether Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XLCIFRJORZNGEV-UHFFFAOYSA-N propan-2-yl 2-[dodecanoyl(methyl)amino]acetate Chemical compound CCCCCCCCCCCC(=O)N(C)CC(=O)OC(C)C XLCIFRJORZNGEV-UHFFFAOYSA-N 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000020122 reconstituted milk Nutrition 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种乳酸菌发酵的桦树汁及其在抗衰老化妆品组合物中的应用,其中所述乳酸菌发酵的桦树汁是通过采用乳酸菌作为菌种在包含桦树汁和任选的乳制品的培养基中进行发酵而得到的。
Description
技术领域
本发明涉及一种乳酸菌发酵的桦树汁及其在抗衰老化妆品组合物中的应用,其中所述乳酸菌发酵的桦树汁通过采用乳酸菌作为菌种在包含桦树汁和任选的乳制品的培养基中进行发酵而得到。
背景技术
桦树为桦木科落叶乔木,桦树汁(也称桦树液)是桦树树皮被划开或树干钻孔流出的新鲜汁液,内含糖类、氨基酸、维生素、生物素、微量的矿质元素、芳香油、桦树醇、皂角甙等化合物,具有良好的保湿、抗炎、抗皱、美白等护肤功效。
发酵技术是指通过微生物的生长繁殖及代谢活动,产生和积累人们所需要的产物的工业技术。据报道,植物提取物通过发酵工艺后可以有提升功效、降低毒性、节省能源等优势。在现有技术中,存在对乳酸菌发酵滤液或菌体应用于食品或皮肤外用品中的研究。但目前尚未见有关将乳酸菌发酵的桦树汁用于化妆品领域的研究报道。
为拓宽发酵的桦树汁的应用,本发明人采用乳酸菌为菌种,以桦树汁为主要底物,任选地向其中添加促生长成分,例如乳制品,进行发酵工艺,所得乳酸菌发酵的桦树汁具有优异的护肤功效,尤其是抗衰老功效。
发明内容
本发明人经研究发现,采用乳酸菌作为菌种,桦树汁作为主要底物,任选地向其中添加乳制品,进行发酵,可以得到一种具有改进性能的乳酸菌发酵的桦树汁,其在具有桦树汁本身活性成分的同时还富含乳酸菌细胞成分和发酵工艺产生的活性成分,例如乳酸、多糖、多酚、黄酮等,从而具有优异的抗衰老功效,可作为皮肤外用组合物、尤其是抗衰老化妆品组合物中的抗衰老活性原料。
一方面,本发明涉及一种生产乳酸菌发酵的桦树汁的方法,其包括采用乳酸菌作为菌种在包含桦树汁和任选的乳制品的培养基中进行发酵的步骤。
所述方法还包括过滤发酵工艺中得到的发酵液,得到作为上清液的发酵的桦树汁滤液(即作为产物的“乳酸菌发酵的桦树汁”),和得到乳酸菌菌体副产物。
进一步地,所述方法还包括破碎所得到的乳酸菌菌体,然后进行过滤,得到作为上清液的可溶性乳酸菌溶胞物,和将所得乳酸菌溶胞物与所述发酵的桦树汁滤液混合,过滤,得到发酵的桦树汁滤液产物(即作为优选产物的“乳酸菌发酵的桦树汁”)。
在一优选的实施方案中,所述方法包括下述步骤:
(1)采用乳酸菌作为菌种,在包含桦树汁和任选的乳制品的培养基中进行发酵,得到发酵液产物;
(2)过滤所述发酵液产物,分别得到乳酸菌菌体和发酵的桦树汁滤液;
(3)破碎所述乳酸菌菌体,然后进行过滤,得到作为上清液的可溶性乳酸菌溶胞物;和
(4)将所得乳酸菌溶胞物与所述发酵的桦树汁滤液混合,过滤,得到发酵的桦树汁滤液产物(即作为优选产物的“乳酸菌发酵的桦树汁”)。
本发明中所采用的乳酸菌包括乳杆菌属(Lactobacillus),双歧杆菌属(Bifidobacterium),以及选自乳球菌属(Lactococcus)、链球菌属(Streptococcus)、片球菌属(Pediococcus)和明串珠菌属(Leuconostoc)等的其它类别的乳酸菌等。所述乳杆菌属(Lactobacillus)包括但不限于嗜酸乳杆菌、干酪乳杆菌、鼠李糖乳杆菌、短乳杆菌、卷曲乳杆菌、德氏乳杆菌(保加利亚亚种、乳亚种)、发酵乳杆菌、瑞士乳杆菌、鸡乳杆菌、加氏乳杆菌、约氏乳杆菌、副干酪乳杆菌、植物乳杆菌、罗伊氏乳杆菌、唾液乳杆菌、消化乳杆菌、弯曲乳杆菌、干酪乳杆菌干酪亚种、清酒乳杆菌。所述双歧杆菌属(Bifidobacterium)包括但不限于青春双歧杆菌、动物双歧杆菌、两岐双岐杆菌、短双歧杆菌、乳双歧杆菌、长双歧杆菌、婴儿双歧杆菌、假小链双歧杆菌。所述其他乳酸菌包括但不限于乳酸乳球菌(乳酸亚种、乳脂亚种、双乙酰亚种)、嗜热链球菌、乳酸链球菌、乳酸片球菌、戊糖片球菌、肠膜明串珠菌、酒明串珠菌等。本发明优选采用的乳酸菌包括嗜酸乳杆菌、干酪乳杆菌、鼠李糖乳杆菌、瑞士乳杆菌、副干酪乳杆菌、植物乳杆菌、罗伊氏乳杆菌、动物双歧杆菌、长双歧杆菌、婴儿双歧杆菌和戊糖片球菌。所述乳酸菌可以菌粉形式商购,例如商购于杜邦公司、科汉森公司、荷兰皇家帝斯曼集团、北京科拓恒通生物技术股份有限公司等。
本发明中所涉及的桦树汁得自桦木科桦树属,其可来自白桦(Betula alba)、柔毛桦(Betula pubescens)、垂枝桦(Betula Pendula)和亚洲白桦(Betula platyphylla)等品种。所述桦树汁为在解冻至早春发叶之间,人工在桦树的树干基部钻孔收集而得的无色透明、无沉淀、无杂物,具有桦树清香营养丰富的汁液。所述桦树汁可商购得到并原样采用,例如可购自大兴安岭超越野生浆果开发有限责任公司。
本发明中可采用的桦树汁为桦树汁原液或浓缩的桦树汁(也称为桦树汁浓缩液),其中浓缩的桦树汁的浓缩倍数为约1.05-10.0倍,优选约1.2-6.0倍,更优选约1.2-3.0倍。
所述浓缩的桦树汁是通过将商购得到的桦树汁产品进行浓缩得到的。浓缩方法是本领域已知的,例如加热浓缩、低温真空浓缩、膜浓缩等。在本发明中,优选通过低温冷冻浓缩或膜浓缩工艺进行浓缩,例如,将商购的桦树汁原液输入低温干燥设备,降温至约-40℃至-70℃,抽真空至约0.1-30Pa而进行低温真空浓缩,从而得到不同浓缩倍数的浓缩桦树汁。
上述步骤(1)发酵是本领域已知的。例如,按照约60-80%(v/v)的装液量,将桦树汁培养基在约95-140℃超高温瞬时杀菌约4-30秒后加入约100-20000升已经空消无菌状态的发酵罐中,或将桦树汁培养基加入约100-20000升发酵罐中,并以约95-121℃灭菌约10-30分钟。按发酵罐中培养基体积计将乳酸菌直投式菌剂或乳酸菌种子液在无菌条件下接入发酵罐中,在约30-45℃温度和约50-350rpm的转速下进行搅拌,通入0-1.0vvm的气体,连续发酵约24-168小时,停罐,即完成发酵过程,得到发酵液产物。
其中,上述乳酸菌直投式菌剂可直接投入发酵罐中。上述乳酸菌种子液是通过使菌粉活化培养得到的。菌粉活化培养是本领域已知的,例如,按照最终发酵体积的约1/50-1/10制备菌种活化步骤的无菌桦树汁种子液培养基;称取约0.1-10克/升、优选约0.5-5克/升以无菌桦树汁种子液培养基计的相应质量的乳酸菌菌粉,将其加入到种子液培养基中,在约30-45℃下培养约4-12小时,即得到所述乳酸菌种子液。
上述桦树汁培养基可以采用桦树汁、尤其是浓缩的桦树汁,例如浓缩1.2-6.0倍的桦树汁浓缩液作为底物来制备。桦树汁在所述桦树汁培养基中的含量在约90%以上,优选约94%以上,基于所述桦树汁培养基的总重量。
优选地,可将作为碳源、氮源的乳制品加入桦树汁培养基中。所述乳制品包括但不限于液态乳、乳粉、乳加工产品和乳加工副产物等。所述液态乳包括例如巴氏杀菌乳、灭菌乳、调制乳、复原乳等。所述乳粉包括例如全脂乳粉、低脂乳粉、脱脂乳粉、羊奶粉等。所述乳加工产品包括例如稀奶油、淡炼乳、干酪、乳酪粉、乳扇等。所述乳加工副产物包括例如乳糖、酪蛋白、水解牛奶蛋白、浓缩乳清蛋白、分离乳清蛋白、乳清蛋白肽等。优选地,所述乳制品包括脱脂乳粉、乳清蛋白(浓缩乳清蛋白、分离乳清蛋白、乳清蛋白肽)。所述乳制品在所述桦树汁培养基中的含量通常为约0-8%,优选约1-5%,基于所述桦树汁培养基的总重量。
进一步地,可将pH调节剂加入到桦树汁培养基中,以将桦树汁培养基的pH调节到5.0-7.0。所述pH调节剂是本领域已知的,例如,包括但不限于乳酸、柠檬酸、氨水、乳酸钠、柠檬酸钠和氢氧化钠,优选柠檬酸钠。
此外,还可以将促进乳酸菌生长的无机盐加入到培养基中,其实例包括但不限于磷酸二氢钾、磷酸二氢钠、磷酸氢二钾、磷酸氢二钠、柠檬酸氢二铵、乙酸钠、硫酸锰、硫酸镁、硝酸钾等。所述无机盐的用量是本领域已知的,通常为约0-2%,优选约0.2-1%,基于所述桦树汁培养基的总重量。
在包含乳制品、pH调节剂和/或无机盐的情况下,将这些物质加入桦树汁中即可制备桦树汁培养基。
上述步骤(2)过滤所得发酵产物是本领域已知的。通常,采用碟式离心机或管式离心机,在约6000-15000rpm下,进行约0.5-15分钟。或者,可通过陶瓷膜或有机膜等进行膜分离过滤。所述过滤步骤将发酵液产物中的乳酸菌菌体和发酵的桦树汁滤液(上清液)分开。
上述步骤(3)破碎所得乳酸菌菌体是本领域已知的。可采用的方式包括且不限于高压破碎法、反复冻融法、酶解法等。例如,使用约3-5倍质量的发酵桦树汁滤液将所得乳酸菌菌体重悬,得到乳酸菌菌体的重悬液,然后采用高压细胞破碎机,在约1-2升/分钟的流速和约800-1200巴的压力下,均匀处理所述重悬液,直至乳酸菌菌体的破碎率达到约98%以上。或者,也可将菌体重悬液在约零下10-20℃冻结,在约30-50℃下复溶,反复5-10次。或者,亦可采用溶菌酶、胰蛋白酶等按约0.2-1.0%添加至重悬液中,基于重悬液的体积,在酶适宜温度下处理约0.5-5小时。然后,将经破碎的乳酸菌菌体重悬液进行过滤,通常在约10000-20000rpm下进行约10-30分钟,所得上清液即为可溶性乳酸菌溶胞物。或者,通过有机膜或陶瓷膜进行分离,分离出的清液即为可溶性乳酸菌溶胞物。
上述步骤(4)中,将步骤(3)所得可溶性乳酸菌溶胞物与步骤(2)所得发酵的桦树汁滤液混合均匀,然后进一步过滤,所得滤液即为乳酸菌发酵的桦树汁滤液产物。
所述方法可进一步包括将所得产物经超高温瞬时杀菌,其中杀菌温度为约95-140℃,时间为约4-30秒;然后,将杀菌过的产物转至存储罐存储,并分装灌装。
通过上述方法得到的乳酸菌发酵的桦树汁色浅、透明,含有桦树汁底物自身的营养成分(其中包括B族维生素、微量元素、氨基酸、脂肪酸等),可溶性乳酸菌溶胞物的营养成分(其中包括多糖、氨基酸、多肽、蛋白、核苷酸等),还有发酵新生成的功效成分(其中包括乳酸、多糖、水解小分子肽、酚酸、黄酮)。通常,所得乳酸菌发酵的桦树汁包含0.1-10g/L的总酚,0.1-5g/L的多糖,0.05-10g/L的氨基酸和0.1-50g/L的多肽。因此,所得乳酸菌发酵的桦树汁含有丰富的活性营养物,可以作为原料营养物用于皮肤外用组合物中,其中包括药物组合物和化妆品组合物,优选地用于抗衰老化妆品组合物中,具有优异的抗衰老功效。
另一方面,本发明涉及一种乳酸菌发酵的桦树汁,其是通过采用乳酸菌作为菌种在包含桦树汁和任选的乳制品的培养基中进行发酵而得到的。
通常,所得乳酸菌发酵的桦树汁包含0.1-10g/L的总酚,0.1-5g/L的多糖,0.05-10g/L的氨基酸和0.1-50g/L的多肽。
再一方面,本发明涉及乳酸菌发酵的桦树汁在抗衰老化妆品组合物中的用途。
又一方面,本发明涉及一种抗衰老化妆品组合物,其包含(A)乳酸菌发酵的桦树汁。
所述乳酸菌发酵的桦树汁在所述抗衰老化妆品组合物中的含量可以在宽范围内变化,例如大于0至小于100%,优选约20-95%,基于所述抗衰老化妆品组合物的总重量。
除了所述乳酸菌发酵的桦树汁外,所述抗衰老化妆品组合物还可以任选地包含(B)抗衰老化妆品组合物中常用的成分,其包括但不限于媒介物、活性成分和辅料等。组分(B)是本领域已知的,本领域技术人员可根据需要选择其类型和用量,例如,组分(B)的含量为约2-82%重量,基于所述抗衰老化妆品组合物的总重量。
所述媒介物包括例如稀释剂、分散剂或载体等,其实例包括但不限于乙醇、双丙甘醇、丁二醇等。所述媒介物在所述抗衰老化妆品组合物中的含量是本领域已知的,例如,其通常占组分(B)总重量的约0.5-20%。
所述活性成分包括例如润肤剂、保湿剂、抗衰老活性成分等。
所述润肤剂的实例包括但不限于橄榄油、澳洲坚果油、甜杏仁油、葡萄籽油、鳄梨油、玉米油、芝麻油、大豆油、花生油、白池花籽油、红花籽油、狗牙蔷薇果油、刺阿干树仁油、霍霍巴籽油、向日葵籽油、毛瑞榈果油、角鲨烷、棕榈酸乙基己酯、肉豆蔻酸异丙酯、氢化聚异丁烯、异十六烷、异十二烷、碳酸二乙基己酯、碳酸二辛酯、月桂酰肌氨酸异丙酯、异壬酸异壬酯、氢化聚癸烯、甘油三(乙基己酸)酯、鲸蜡醇乙基己酸酯、双-二乙氧基二甘醇环己烷1,4-二羧酸酯、辛酸/癸酸甘油三酯、油醇芥酸酯、辛基十二醇肉豆蔻酸酯、辛基十二醇、聚二甲基硅氧烷、辛基聚甲基硅氧烷、鲸蜡基聚二甲基硅氧烷、环五聚二甲基硅氧烷等的一种或多种。固体润肤剂的实例包括但不限于鲸蜡醇、硬脂醇、鲸蜡硬脂醇、山嵛醇、鲨肝醇、月桂酸、肉豆蔻酸、棕榈酸、硬脂酸、蜂蜡、小烛树蜡、巴西棕榈蜡、羊毛脂、地蜡、霍霍巴籽蜡、石蜡、微晶蜡、氢化米糠蜡、氢化椰油甘油酯类、甘油山嵛酸酯/二十酸酯、肉豆蔻醇肉豆蔻酸酯、双-二甘油多酰基己二酸酯-2、牛油果树果脂、木鲁星果棕籽脂等中的一种或多种。所述润肤剂在所述抗衰老化妆品组合物中的含量是本领域已知的,例如,其通常占组分(B)总重量的约1-50%。
所述保湿剂的实例包括但不限于甘油、双甘油、丁二醇、丙二醇、1,3-丙二醇、双丙甘醇、1,2-戊二醇、聚乙二醇-8、聚乙二醇-32、甲基葡糖醇聚醚-10、甲基葡糖醇聚醚-20、PEG/PPG-17/6共聚物、甘油聚醚-7、甘油聚醚-26、甘油葡糖苷、PPG-10甲基葡糖醚、PPG-20甲基葡糖醚、PEG/PPG/聚丁二醇-8/5/3甘油、蔗糖、海藻糖、鼠李糖、甘露糖、棉子糖、甜菜碱、赤藓醇、木糖醇、尿素、甘油聚醚-5乳酸酯、透明质酸钠、水解透明质酸钠、乙酰化透明质酸钠、聚谷氨酸钠、水解小核菌胶、出芽短梗酶多糖、银耳多糖、酸豆籽多糖等中的一种或多种。所述保湿剂在所述抗衰老化妆品组合物中的含量是本领域已知的,例如,其通常占组分(B)总重量的约1-30%。
所述抗衰老活性成分的实例包括但不限于生育酚(维生素E)、视黄醇、视黄醇棕榈酸酯、水解胶原、水解弹性蛋白、尿囊素、酵母提取物、谷维素、四氢姜黄素、鞣花酸、泛醌、乳清蛋白、乙酰基六肽-8、棕榈酰五肽-4、水杨酰植物鞘氨醇、浓缩桦树汁、水飞蓟素、蚕丝胶蛋白、生育酚磷酸酯钠、核糖核酸(RNA)、二肽二氨基丁酰苄基酰胺二乙酸盐、棕榈酰三肽-5、寡肽-1、六肽-9、棕榈酰寡肽、棕榈酰四肽-7、葡萄(VITIS VINIFERA)籽提取物、花榈木(PTEROCARPUS MARSUPIUM)树皮提取物、茶(CAMELLIA SINENSIS)多酚、葡萄酒提取物、苹果籽提取物、欧洲水青冈(FAGUS SYLVATICA)芽提取物、水解猴面包树(ADANSONIA DIGITATA)提取物、卤虫(ARTEMIA)提取物、香根鸢尾(IRIS FLORENTINA)根提取物、橙皮苷、人参皂甙、丹参(SALVIA MILTIORRHIZA)提取物、烟酰胺、熊果酸、透明质酸钠、乙酰化透明质酸钠、水解透明质酸钠、番茄红素、咖啡(COFFEA ARABICA)提取物、二肽-2、乳酸、超氧化物歧化酶(SOD)、月见草(OENOTHERA BIENNIS)油、神经酰胺、二棕榈酰羟脯氨酸、羟基硬脂酸、水杨酸、麦角硫因、溶血卵磷脂、肌肽、脱羧肌肽HCL、硫辛酸、腺苷、糖原、白藜芦醇、阿魏酸、二裂酵母发酵产物溶胞物、乳酸菌发酵溶胞产物等中的一种或多种。所述抗衰老成分在所述抗衰老化妆品组合物中的含量是本领域已知的,例如,其通常占组分(B)总重量的约0.01-10%。
所述辅料包括例如乳化剂、增稠剂、防腐剂、香料等。
所述乳化剂的实例包括但不限于鲸蜡硬脂醇橄榄油酸酯、山梨坦橄榄油酸酯、聚山梨醇酯-60、聚山梨醇酯-80、甲基葡糖倍半硬脂酸酯、PEG-20甲基葡糖倍半硬脂酸酯、PEG-40氢化蓖麻油、PPG-26-丁醇聚醚-26、PEG-4聚甘油-2硬脂酸酯、PEG-60氢化蓖麻油、硬脂醇聚醚-2、硬脂醇聚醚-21、PPG-13-癸基十四醇聚醚-24、鲸蜡硬脂基葡糖苷、PEG-100硬脂酸酯、甘油硬脂酸酯、甘油硬脂酸酯SE、椰油基葡糖苷、鲸蜡硬脂醇聚醚-25、PEG-40硬脂酸酯、聚甘油-3甲基葡糖二硬脂酸酯、甘油硬脂酸酯柠檬酸酯、聚甘油-10硬脂酸酯、聚甘油-10肉豆蔻酸酯、聚甘油-10二油酸酯、聚甘油-10月桂酸酯、聚甘油-10异硬脂酸酯、聚甘油-10油酸酯、聚甘油-10二异硬脂酸酯、聚甘油-6月桂酸酯、聚甘油-6肉豆蔻酸酯、蔗糖硬脂酸酯、蔗糖多硬脂酸酯等中的一种或多种。所述乳化剂在所述抗衰老化妆品组合物中的含量是本领域已知的,例如,其通常占组分(B)总重量的约0.5-10%。
所述增稠剂的实例包括但不限于卡波姆类、丙烯酸(酯)类及其衍生物、黄原胶、阿拉伯胶、聚乙二醇-14M、聚乙二醇-90M、琥珀酰聚糖、羟乙基纤维素、羟丙基纤维素、羟丙基甲基纤维素等高分子聚合物中的一种或多种。所述增稠剂在所述抗衰老化妆品组合物中的含量是本领域已知的,例如,其通常占组分(B)总重量的约0.1-10%。
所述防腐剂的实例包括但不限于羟苯甲酯、羟苯丙酯、苯氧乙醇、苯甲醇、苯乙醇、双(羟甲基)咪唑烷基脲、山梨酸钾、苯甲酸钠、氯苯甘醚、脱氢乙酸钠、辛酰羟肟酸、1,2-己二醇、1,2-戊二醇、对羟基苯乙酮、辛甘醇、甘油辛酸酯、十一碳烯酸甘油酯、山梨坦辛酸酯、乙基己基甘油、牡丹根提取物等中的一种或多种。所述防腐剂在所述抗衰老化妆品组合物中的含量是本领域已知的,例如,其通常占组分(B)总重量的约0.01-2%。
可根据化妆品工业中已知的任何方法,将(A)乳酸菌发酵的桦树汁与其它药物成分或者化妆品成分混合,得到化妆品组合物。例如,使用化妆品领域中常用的溶解槽、乳化锅、分散器、输送泵等设备制备。制备时先将水溶性物质投入水相溶解釜,将油溶性物质投入油相溶解釜,将两个釜的温度加热至约80℃,其中对于易结块的原料,可先用分散器将其预分散。待溶解完成后将油相和水相输送至乳化锅中,均质乳化约5-15分钟。乳化完成后将料体温度降至常温,加入任选的香精、防腐剂等,并视需要调节产物的pH。相关检测指标都合格后方可灌装出货。以上制备方法可根据剂型要求进行删减或调整。
所述抗衰老化妆品组合物可根据需要制成各种剂型,例如溶液、悬浮液、膏、霜、乳液、凝胶、粉末、喷剂等。
实施例
以下结合实施例,对本发明进行进一步详细说明。但是,应当理解为,这些实施例、对比例仅仅是用于更详细地说明本发明,而不应理解为用于以任何形式限制本发明所附权利要求书的范围。
实施例1-6中采用的干酪乳杆菌(Lactobacillus casei)菌种商购于北京科拓恒通生物技术股份有限公司,菌种编号LC-Zhang;瑞士乳杆菌(Lactobacillus helveticus)菌种商购于杜邦公司,菌种编号FLAV54;戊糖片球菌(Pediococcus pentosaceus)商购于杜邦公司,菌种编号P751;罗伊氏乳杆菌(Lactobacillus reuteri)商购于荷兰皇家帝斯曼集团,菌种编号DSM17938;动物双歧杆菌(Bifidobacterium animalis)商购于科汉森公司,菌种编号BB-12。
实施例1
(1)桦树汁培养基的制备
以东北大兴安岭采集的桦树汁原液(brix 1.20)为底物,添加0.2%乙酸钠、0.2%柠檬酸氢二铵、0.05%硫酸镁和0.02%硫酸锰,使用1M柠檬酸钠水溶液调整桦树汁培养基的pH为5.8±0.2。
(2)干酪乳杆菌种子液的制备
制备8升桦树汁培养基并在105℃灭菌20分钟,冷却至37℃后,按1克/升投入干酪乳杆菌粉,以培养基体积计;在37℃环境中培养8小时,得到干酪乳杆菌种子液。
(3)接种发酵
按照72%(v/v)体积装液量,将步骤(1)所配制的桦树汁培养基加入到100升发酵罐中,105℃灭菌20分钟;将所制备的干酪乳杆菌种子液无菌操作接入发酵罐中,于37℃、搅拌转速150rpm的条件下,连续发酵72小时,停罐,得到发酵液产物。
(4)陶瓷膜分离,得到发酵滤液和菌体
使用0.2μm陶瓷膜处理发酵液产物,其中操作压力0.15MPa,操作温度10℃;得到作为上清液的发酵的桦树汁滤液并打入无菌储存罐;和得到作为菌泥的干酪乳杆菌菌体,并将其用5倍体积上清液重悬,得到干酪乳杆菌重悬液。
(5)破碎,过滤,得到可溶性干酪乳杆菌溶胞物
利用高压细胞破碎设备,在900±50巴、1.5升/分钟流速的条件下,将步骤(4)所得干酪乳杆菌重悬液进行高压细胞破碎;然后使用0.2μm陶瓷膜过滤,即得到可溶性的干酪乳杆菌溶胞物。
(6)将干酪乳杆菌溶胞物与发酵的桦树汁滤液混合和过滤将步骤(5)所得干酪乳杆菌溶胞物与步骤(4)所得发酵的桦树汁滤液混合,然后使用0.2μm陶瓷膜过滤,得到最终发酵的桦树汁滤液产物。
取发酵的桦树汁滤液产物,测定其中的总酚、多糖、氨基酸和多肽含量,结果如表1所示;测定对重组3D全层皮肤模型的影响,结果如表2所示。
实施例2
(1)浓缩的桦树汁培养基的制备
以来自东北小兴安岭的桦树汁的浓缩液(浓缩6倍,brix 6.10)为底物,添加0.2%柠檬酸氢二铵、0.1%磷酸二氢钾、0.05%硫酸镁和0.02%硫酸锰,使用0.5M氢氧化钠水溶液调整桦树汁培养基的pH为5.8±0.2。
(2)接种发酵
按照70%(v/v)体积装液量,将步骤(1)所配制的桦树汁培养基通过超高温瞬时杀菌设备128℃灭菌4秒;加入到1000升已经空罐杀菌后的发酵罐中并将培养基冷却至35℃;将商购的瑞士乳杆菌菌粉按3克/升无菌操作投入发酵罐中,于35℃、搅拌转速200rpm的条件下,连续发酵60小时,停罐,得到发酵液产物。
(3)管式离心机分离,得到发酵液和菌体
使用管式离心机处理发酵液,其中搅拌转速13000rpm,操作温度10℃,流速160升/小时;得到作为上清液的发酵的桦树汁滤液并打入无菌储存罐;和得到作为菌泥的瑞士乳杆菌菌体,并将其用4倍体积上清液重悬,得到瑞士乳杆菌重悬液。
(4)破碎,过滤,得到可溶性瑞士乳杆菌溶胞物
将步骤(3)所得瑞士乳杆菌重悬液进行反复冻融破碎,将重悬液置于零下20℃速冷冻结后,在40℃复融,周期循环5次。然后使用管式离心机过滤,即得到可溶性的瑞士乳杆菌溶胞物。
(5)将瑞士乳杆菌溶胞物与发酵桦树汁滤液混合过滤
将步骤(4)所得瑞士乳杆菌溶胞物与步骤(3)所得发酵的桦树汁滤液混合,然后使用0.2μm陶瓷膜过滤,得到最终发酵的桦树汁滤液产物。
(6)将发酵桦树汁滤液杀菌灌装
将步骤(5)所得的发酵的桦树汁滤液产物经超高温瞬时杀菌设备,杀菌温度为110℃,杀菌15秒;然后,将杀菌过的滤液产物灌装于无菌袋中。
取发酵的桦树汁滤液产物,测定其中的总酚、多糖、氨基酸和多肽含量,结果如表1所示;和测定对重组3D全层皮肤模型的影响,结果如表2所示。
实施例3
(1)桦树汁培养基的制备
以东北小兴安岭采集的桦树汁原液(brix1.05)为底物,添加7%脱脂乳粉、0.05%硫酸镁和0.02%硫酸锰,使用1M柠檬酸钠水溶液调整桦树汁培养基的pH为5.8±0.2。
(2)戊糖片球菌种子液的制备
制备35升步骤(1)的桦树汁培养基并通过超高温瞬时杀菌设备135℃灭菌3秒后无菌转移到50升无菌发酵罐中,冷却至32℃后,按1.5克/升投入戊糖片球菌菌粉,以培养基体积计;在32℃环境中培养8小时,得到戊糖片球菌种子液。
(3)接种发酵
按照70%(v/v)体积装液量,将步骤(1)所配制的桦树汁培养基通过超高温瞬时杀菌设备135℃灭菌3秒后无菌转移到500升无菌发酵罐中;将步骤(2)所制备的戊糖片球菌种子液无菌操作接入发酵罐中,于32℃、搅拌转速100rpm的条件下,连续发酵54小时,停罐,得到发酵液产物。
(4)离心机分离,得到发酵滤液和菌体
使用碟式离心机处理发酵液,其中搅拌转速9000rpm,操作温度20℃,分离时间20分钟,得到作为上清液的最终发酵的桦树汁滤液产物,和作为菌泥的戊糖片球菌菌体。
取发酵的桦树汁滤液产物,测定其中的总酚、多糖、氨基酸和多肽含量,结果如表1所示;和测定对重组3D全层皮肤模型的影响,结果如表2所示。
实施例4
(1)桦树汁培养基的制备
以东北小兴安岭采集的桦树汁原液(brix0.95)为底物,添加4%脱脂乳粉、1%水解牛奶蛋白、0.2%硝酸钾、0.05%硫酸镁,使用1M柠檬酸钠水溶液调整桦树汁培养基的pH为5.8±0.2。
(2)接种发酵
按照70%(v/v)体积装液量,将步骤(1)所配制的桦树汁培养基通过超高温瞬时杀菌设备121℃灭菌15秒后无菌转移到10000升无菌发酵罐中;将动物双歧杆菌菌粉无菌操作接入发酵罐中,于42℃、搅拌转速100rpm、通入0.3vvm的二氧化碳气体的条件下,连续发酵48小时,停罐,得到发酵液产物。
(3)离心机分离,得到发酵滤液和菌体
使用管式离心机处理发酵液产物,其中搅拌转速6000rpm,操作温度10℃,分离时间15分钟;得到作为上清液的发酵的桦树汁滤液并打入无菌储存罐;和得到作为菌泥的双歧杆菌菌体,并将其用5倍体积上清液重悬,得到动物双歧杆菌重悬液。
(4)破碎,过滤,得到可溶性动物双歧杆菌溶胞物
将步骤(3)所得动物双歧杆菌重悬液进行酶解细胞破碎,其中添加0.8%的溶菌酶在35℃酶解处理60分钟,在200巴、1.3升/分钟流速的条件下进行均质破碎。然后使用0.2μm陶瓷膜过滤,即得到可溶性的动物双歧杆菌溶胞物。
(5)将动物双歧杆菌溶胞物与发酵的桦树汁滤液混合和过滤将步骤(4)所得动物双歧杆菌溶胞物与步骤(3)所得发酵的桦树汁滤液混合,然后使用0.2μm陶瓷膜过滤,得到最终发酵的桦树汁滤液产物。
(6)将发酵的桦树汁滤液杀菌灌装
将步骤(5)所得的发酵桦树汁滤液经超高温瞬时杀菌设备,杀菌温度为132℃,杀菌4秒;然后,将杀菌过的滤液灌装于无菌袋中。
取发酵的桦树汁滤液产物,测定其中的总酚、多糖、氨基酸和多肽含量,结果如表1所示;和测定对重组3D全层皮肤模型的影响,结果如表2所示。
实施例5
(1)桦树汁培养基的制备
以来自东北小兴安岭的桦树汁的浓缩液(浓缩3倍,brix 2.95)为底物,添加2%乳清蛋白粉,使用0.5M氢氧化钠水溶液调整桦树汁培养基的pH为5.8±0.2。
(2)接种发酵
按照60%(v/v)体积装液量,将步骤(1)所配制的桦树汁培养基通过超高温瞬时杀菌设备115℃灭菌20秒后无菌转移到20000升无菌发酵罐中;将罗伊氏乳杆菌粉无菌操作接入发酵罐中,于42℃、搅拌转速200rpm的条件下,连续发酵84小时,停罐,得到发酵液产物。
(3)离心机分离,得到发酵滤液和菌体
使用管式离心机处理发酵液产物,其中搅拌转速14000rpm,操作温度10℃,分离流速为150升/小时;得到作为上清液的发酵的桦树汁滤液并打入无菌储存罐;和得到作为菌泥的罗伊氏乳杆菌菌体,并将其用5倍体积上清液重悬,得到罗伊氏乳杆菌重悬液。
(4)破碎,过滤,得到可溶性罗伊氏乳杆菌溶胞物
利用高压细胞破碎设备,在800巴、1升/分钟流速的条件下,将步骤(3)所得罗伊氏乳杆菌重悬液进行高压细胞破碎;然后使用离心机过滤,即得到可溶性的罗伊氏乳杆菌溶胞物。
(5)将罗伊氏乳杆菌溶胞物与发酵的桦树汁滤液混合和过滤将步骤(4)所得罗伊氏乳杆菌溶胞物与步骤(3)所得发酵的桦树汁滤液混合,然后进一步使用离心机过滤,得到最终发酵的桦树汁滤液产物。
取发酵的桦树汁滤液产物,测定其中的总酚、多糖、氨基酸和多肽含量,结果如表1所示;和测定对重组3D全层皮肤模型的影响,结果如表2所示。
表1:发酵的桦树汁滤液产物的总酚、胞外多糖、氨基酸、多肽含量
从结果表明,与桦树汁原液相比,通过乳酸菌发酵桦树汁或浓缩的桦树汁得到的发酵产物中的营养物质明显增加。通过进一步添加乳制品,所得的发酵产物中的多项营养物质进一步增加,尤其是其中的多糖含量、氨基酸含量。
表2:发酵的桦树汁滤液产物对重组3D全层皮肤模型的影响
注:*表示与原汁相比为显著,P值小于0.05;**表示与原汁相比为极显著,P值小于0.01。
MTT值测试结果表明,与桦树汁原液相比,发酵的桦树汁滤液产物能够显著地提高重组3D全层皮肤模型的组织活力。类似的,使用浓缩的桦树汁作为底物的发酵桦树汁滤液的3D皮肤模型真表皮连接处胶原蛋白IV相对表达量显著高于桦树汁原汁作为底物的发酵桦树汁滤液。以上结果还表明,添加了乳制品发酵后的发酵的桦树汁滤液能够极显著地提高重组3D全层皮肤模型的组织活力,促进真表皮连接处胶原蛋白IV相对表达量,同时能够减少细胞外基质中的MMP-1的表达。
实施例7:抗衰老爽肤水
在该实施例中,采用实施例1中制备的发酵的桦树汁滤液产物来制备该爽肤水,其配方如下:
成分 | 含量(质量%) |
发酵的桦树汁滤液产物 | 94.25 |
苯甲酸钠 | 0.25 |
1,2-戊二醇 | 5 |
焦亚硫酸钠 | 0.5 |
上述爽肤水如下制备:
将所述发酵的桦树汁滤液产物、苯甲酸钠和戊二醇、焦亚硫酸钠混合,然后过滤,即得。
在本实施例中,测试了上述爽肤水对重组3D全层皮肤模型的影响,其中选用20名受试者对使用情况进行主观评估。结果显示,有18人反映皮肤含水量显著增加,皮肤光滑细嫩有弹性,这表明,该配方能够显著地提高重组3D全层皮肤模型的组织活力,促进真表皮连接处胶原蛋白IV相对表达量,同时能够减少细胞外基质中的MMP-1的表达。
实施例8:抗衰老面霜
在该实施例中,采用实施例2中制备的发酵的桦树汁滤液产物来制备该面霜,其配方如下:
上述面霜如下制备:
1)油相:将4、6、7、8、9、11、12、13、15、21号原料加入油相锅,并加热至80℃,溶解,混合均匀;
2)将2、16、18号原料在常温下混合均匀;
3)将10、14、17、20号原料等原料在常温下混合均匀;
4)水相:将1、3、5号原料加热到80℃,加入步骤2的混合物,溶解,混合均匀;
5)乳化:将水相和油相加入乳化罐中,保温在80℃,在3000rpm速度下均质乳化5分钟,乳化完成后加入19号原料;
6)搅拌降温至40℃时加入步骤3的混合物,搅拌均匀后出料,得到所述抗衰老面霜。
20名受试者使用上述面霜4周后,对使用情况进行主观评估。结果有18人反映皮肤含水量显著增加,皮肤光滑细嫩有弹性,且其中有16人反映法令纹和眼角皱纹有明显改善。
实施例9:抗衰老乳液
在该实施例中,采用实施例3中制备的发酵的桦树汁滤液产物来制备该乳液,其配方如下:
原料 | 重量% | |
1 | 发酵的桦树汁滤液产物 | 67.55 |
2 | 甘油 | 6.00 |
3 | 双丙甘醇 | 5.00 |
4 | 角鲨烷 | 5.00 |
5 | 牛油果树(BUTYROSPERMUM PARKII)果脂 | 2.00 |
6 | 合成鲸蜡 | 1.00 |
7 | 异十二烷 | 2.00 |
8 | 黄原胶 | 0.10 |
9 | 乙酰基六肽-8 | 8.50 |
10 | 乙酰化透明质酸钠 | 0.05 |
11 | 丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物 | 0.10 |
12 | PEG-100硬脂酸酯,甘油硬脂酸酯 | 1.00 |
13 | C14-22醇,C12-20烷基葡糖苷 | 1.00 |
14 | 羟苯甲酯 | 0.20 |
15 | 精氨酸 | 0.10 |
16 | 苯氧乙醇 | 0.40 |
上述乳液如下制备:
1)油相:将4、5、6、7、12、13号原料加入油相锅,并加热至80℃,溶解,混合均匀;
2)将2、8、11号原料在常温下混合均匀;
3)将9、10、16号原料等原料在常温下混合均匀;
4)水相:将1、3、14号原料加热到80℃,加入步骤2的混合物。
溶解,混合均匀;
5)乳化:将水相和油相加入乳化罐中,保温在80℃,在3000rpm速度下均质乳化5分钟,乳化完成后加入15号原料;
6)搅拌降温至40℃时加入步骤3的混合物,搅拌均匀后出料,得到所述抗衰老乳液。
20名受试者使用上述乳液4周后,对使用情况进行主观评估。结果有18人反映皮肤含水量显著增加,皮肤光滑细嫩有弹性,且其中有14人反映法令纹和眼角皱纹有明显改善。
实施例10:抗衰老眼霜
在该实施例中,采用实施例4中制备的发酵的桦树汁滤液产物来制备该眼霜,其配方如下:
序号 | 原料 | 重量% |
1 | 发酵的桦树汁滤液产物 | 70.75 |
2 | 甘油 | 6.00 |
3 | 甘油三(乙基己酸)酯 | 3.00 |
4 | 丁二醇 | 5.00 |
5 | 聚二甲基硅氧烷 | 2.00 |
6 | C12-20烷基葡糖苷、C14-22醇 | 2.00 |
7 | 鲸蜡醇 | 2.00 |
8 | 肌酸 | 2.00 |
9 | 苯基聚三甲基硅氧烷 | 1.00 |
10 | 六肽-9 | 3.00 |
11 | 甘油硬脂酸酯类、PEG-100硬脂酸酯 | 0.50 |
12 | 苯氧乙醇 | 0.50 |
13 | 泛醇 | 0.30 |
14 | 二肽二氨基丁酰苄基酰胺二乙酸盐 | 1.00 |
15 | 精氨酸 | 0.15 |
16 | 卡波姆 | 0.25 |
17 | 乙酰化透明质酸钠 | 0.10 |
18 | 羟苯甲酯 | 0.10 |
19 | 尿囊素 | 0.15 |
20 | 聚谷氨酸钠 | 0.20 |
上述眼霜如下制备:
1)油相:将3、5、6、7、9、11号原料加入油相锅,并加热至80℃,溶解,混合均匀;
2)将2、16号原料在常温下混合均匀;
3)将10、14、17号原料等原料在常温下混合均匀;
4)水相:将1、4、8、13、18、19、20号原料加热到80℃,加入步骤2的混合物,溶解,混合均匀;
5)乳化:将水相和油相加入乳化罐中,保温在80℃,在3000rpm速度下均质乳化5分钟,乳化完成后加入12、15号原料;
6)搅拌降温至40℃时加入步骤3的混合物,搅拌均匀后出料,得到所述抗衰老眼霜。
采用半脸对照的测试方法,在使用该眼霜前和4周后分别对20名志愿者进行如下测试:
1)用primos对志愿者左右两侧外眼角拍照,用软件计算皱纹参数,其中包括皱纹数量、皱纹面积、皱纹深度等;
2)用Corneometer测试左右两侧眼角的皮肤水分含量。
结果显示,20名受试者中有18人眼角皮肤含水量显著增加,其中有15人眼角皱纹明显变浅变淡,皱纹面积减小,皱纹数量减少。
实施例7:抗衰老精华液
在该实施例中,采用实施例5中制备的发酵的桦树汁滤液产物来制备该精华液,其配方如下:
原料 | 重量% | |
1 | 发酵的桦树汁滤液 | 73.00 |
2 | PPG-10甲基葡糖醚 | 4.00 |
3 | PEG/PPG-17/6共聚物 | 2.00 |
4 | 海藻糖 | 2.00 |
5 | 甘油 | 6.00 |
6 | 1,3-丙二醇 | 5.00 |
7 | 棕榈酰三肽-5 | 2.50 |
8 | 二肽二氨基丁酰苄基酰胺二乙酸盐 | 1.30 |
9 | 乙酰化透明质酸钠 | 0.30 |
10 | 丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物 | 0.20 |
11 | 黄原胶 | 0.10 |
12 | 泛醇 | 0.50 |
13 | 羟苯甲酯 | 0.15 |
14 | 精氨酸 | 0.35 |
15 | 卤虫(ARTEMIA)提取物 | 2.20 |
16 | 苯氧乙醇 | 0.40 |
上述精华液如下制备:
1)将1、2、3、4、6、12、13号原料加入乳化罐中,保温在80℃;
2)将5、10、11号原料在常温下混合均匀;
3)将7、8、9号原料在常温下混合均匀;
4)加入14号原料,调节pH值;
5)搅拌降温至40℃时加入15号、16号和步骤3原料,搅拌均匀后出料,得到抗衰老精华液。
采用半脸对照的测试方法,在使用产品前和使用产品8周后分别对20名志愿者进行如下测试:
1)用primos对志愿者左右两侧外眼角拍照,用软件计算皱纹参数,其中包括皱纹数量、皱纹面积、皱纹深度等;
结果显示,20名受试者中有16人眼角皱纹明显变浅变淡,皱纹面积减小,皱纹数量减少。
2)用Tewameter测试左右两侧脸颊经皮失水率(TEWL值)。
结果显示,20名受试者中有19人皮肤含水量显著增加,TEWL值明显降低。其中有17人法令纹和眼角皱纹明显变浅变淡,皱纹面积减小,皱纹数量减少。
以上所述实施例的技术方案是本发明优选实施方式,在不脱离本发明原理的前提下还可以进行若干改进和变换,这些改进和变化也应视为在本发明的保护范围内。
Claims (10)
1.一种生产乳酸菌发酵的桦树汁的方法,其包括下述步骤:
(1)采用乳酸菌作为菌种,在包含桦树汁和任选的乳制品的培养基中,在30-45℃温度下进行发酵24-168小时,得到发酵液产物;
(2)过滤所述发酵液产物,分别得到乳酸菌菌体和发酵的桦树汁滤液;
(3)破碎所述乳酸菌菌体,然后进行过滤,得到作为上清液的可溶性乳酸菌溶胞物;和
(4)将所得乳酸菌溶胞物与所述发酵的桦树汁滤液混合,过滤,得到发酵的桦树汁滤液产物,即,乳酸菌发酵的桦树汁;
其中,所述乳酸菌选自嗜酸乳杆菌、干酪乳杆菌、鼠李糖乳杆菌、瑞士乳杆菌、副干酪乳杆菌、植物乳杆菌、罗伊氏乳杆菌、动物双歧杆菌、长双歧杆菌、婴儿双歧杆菌和戊糖片球菌;
所述桦树汁在所述桦树汁培养基中的含量在90%以上,基于所述桦树汁培养基的总重量。
2.权利要求1所述的方法,其中所述桦树汁是浓缩倍数为1.05-6.0倍的浓缩的桦树汁。
3.权利要求2所述的方法,其中所述桦树汁是浓缩倍数为1.2-6.0倍的浓缩的桦树汁。
4.权利要求1-3任一项所述的方法,其中所述桦树汁在所述桦树汁培养基中的含量在94%以上,基于所述桦树汁培养基的总重量。
5.权利要求1-3任一项所述的方法,其中所述乳制品选自液态乳、乳粉、乳加工产品和乳加工副产物。
6.权利要求1-3任一项所述的方法,其中所述乳制品在所述桦树汁培养基中的含量为0-8%,基于所述桦树汁培养基的总重量。
7.权利要求6所述的方法,其中所述乳制品在所述桦树汁培养基中的含量为1-5%。
8.通过权利要求1-7任一项所述的方法得到的乳酸菌发酵的桦树汁。
9.权利要求8所述的乳酸菌发酵的桦树汁在制备抗衰老化妆品组合物中的用途。
10.一种抗衰老化妆品组合物,其包含权利要求8所述的乳酸菌发酵的桦树汁。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911189170.8A CN112957307B (zh) | 2019-11-28 | 2019-11-28 | 乳酸菌发酵的桦树汁及其在抗衰老化妆品组合物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911189170.8A CN112957307B (zh) | 2019-11-28 | 2019-11-28 | 乳酸菌发酵的桦树汁及其在抗衰老化妆品组合物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112957307A CN112957307A (zh) | 2021-06-15 |
CN112957307B true CN112957307B (zh) | 2023-06-02 |
Family
ID=76270749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911189170.8A Active CN112957307B (zh) | 2019-11-28 | 2019-11-28 | 乳酸菌发酵的桦树汁及其在抗衰老化妆品组合物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112957307B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102615522B1 (ko) * | 2021-10-01 | 2023-12-20 | 주식회사 코리아나화장품 | 발효 만주자작나무수액을 유효성분으로 함유하는 보습용 화장료 조성물 |
CN114317617B (zh) * | 2021-12-20 | 2023-06-27 | 无锡弘焕微生态科技有限公司 | 具有抗皱功效的三重益生菌发酵复合物制备方法及其应用 |
WO2023249017A1 (ja) * | 2022-06-20 | 2023-12-28 | 丸善製薬株式会社 | 抗老化剤、育毛剤および抗男性ホルモン剤 |
CN115595333B (zh) * | 2022-12-15 | 2023-04-07 | 朗肽生物制药股份有限公司 | 一种复合乳酸菌发酵溶胞物及其制备方法、应用 |
CN115812954A (zh) * | 2022-12-23 | 2023-03-21 | 伊春桦肽生物药业有限公司 | 一种桦树汁酵素及其制备方法 |
CN115804746B (zh) * | 2023-02-07 | 2023-05-23 | 广州杨森药业有限公司 | 一种发酵桦树汁的制备方法及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008120712A1 (ja) * | 2007-03-30 | 2008-10-09 | Suntory Holdings Limited | 交感神経活動亢進作用を有する医薬組成物又は飲食物 |
CN107049865A (zh) * | 2017-04-27 | 2017-08-18 | 养生堂(上海)化妆品研发有限公司 | 护肤化妆品组合物 |
CN108836919A (zh) * | 2018-09-21 | 2018-11-20 | 北京崇珍科贸有限公司 | 保湿化妆品组合物及其制备方法和应用 |
-
2019
- 2019-11-28 CN CN201911189170.8A patent/CN112957307B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008120712A1 (ja) * | 2007-03-30 | 2008-10-09 | Suntory Holdings Limited | 交感神経活動亢進作用を有する医薬組成物又は飲食物 |
CN107049865A (zh) * | 2017-04-27 | 2017-08-18 | 养生堂(上海)化妆品研发有限公司 | 护肤化妆品组合物 |
CN108836919A (zh) * | 2018-09-21 | 2018-11-20 | 北京崇珍科贸有限公司 | 保湿化妆品组合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN112957307A (zh) | 2021-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112957307B (zh) | 乳酸菌发酵的桦树汁及其在抗衰老化妆品组合物中的应用 | |
CN110731924B (zh) | 增强的抗衰老化妆品组合物 | |
CN112842950B (zh) | 乳酸菌发酵的桦树汁及其在具有抗环境压力功效的化妆品组合物中的应用 | |
WO2021017833A1 (zh) | 抗衰老化妆品组合物 | |
CN112842953B (zh) | 酵母菌发酵的桦树汁及其在保湿化妆品组合物中的应用 | |
CN110772459B (zh) | 酵母菌发酵的桦树汁及其在美白化妆品组合物中的应用 | |
CN112402333B (zh) | 红米发酵提取物在制备化妆品中的应用 | |
JP2021019577A (ja) | 発酵カバノキ樹液及びその製造方法 | |
JP2016084303A (ja) | 抗酸化剤、皮膚化粧料及び毛髪化粧料 | |
JP2019038760A (ja) | 皮膚外用剤 | |
CN109939064A (zh) | 含益生菌发酵代谢产物的精华液及其在化妆品中的应用 | |
CN105012219B (zh) | 藏灵菇菌发酵乳提取物制备及其在化妆品中的应用 | |
KR20160129453A (ko) | 마태반 발효물 및 마유를 함유하는 피부 주름개선 화장료 조성물 | |
TWI701033B (zh) | 膠原纖維的集束能增強劑 | |
US8591882B2 (en) | Cytoprotective agent | |
CN112842951B (zh) | 二次发酵的桦树汁及其在皮肤外用组合物中的应用 | |
CN112842952B (zh) | 酵母菌发酵的桦树汁及其在防脱生发组合物中的应用 | |
JP4674286B2 (ja) | 乳化剤及び化粧料 | |
JP2002193735A (ja) | 皮膚外用組成物及びその製造方法 | |
CN112842976B (zh) | 酵母菌发酵的桦树汁及其在抗炎化妆品组合物中的应用 | |
KR100467068B1 (ko) | 락토코쿠스 락티스 씨비티-19, 이를 이용한 항균 배양액분리 농축물의 제조 방법 및 이를 포함하는 화장료 조성물 | |
JP6362836B2 (ja) | 乳化剤 | |
JP2021185879A (ja) | 酵母培養物抽出物及び当該抽出物を含む皮膚外用剤 | |
CN112402455B (zh) | 牦牛奶发酵提取物的应用 | |
KR20170140729A (ko) | 선복화 추출물의 적합성 시험방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |